PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
Free Cash Flow
PYC Therapeutics Ltd
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
PYC Therapeutics Ltd
ASX:PYC
|
Free Cash Flow
-AU$20m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-21%
|
|
Immutep Ltd
ASX:IMM
|
Free Cash Flow
-AU$35.4m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
|
Mesoblast Ltd
ASX:MSB
|
Free Cash Flow
-$59.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Free Cash Flow
$1.2B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
4%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Free Cash Flow
AU$36.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Free Cash Flow
AU$13.1m
|
CAGR 3-Years
100%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Free Cash Flow?
Free Cash Flow
-20m
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Free Cash Flow amounts to -20m AUD.
What is PYC Therapeutics Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-21%
Over the last year, the Free Cash Flow growth was 24%. The average annual Free Cash Flow growth rates for PYC Therapeutics Ltd have been -24% over the past three years , -47% over the past five years , and -21% over the past ten years .